SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wisee who wrote (582)5/8/1998 8:57:00 AM
From: F. Jay Abella, III  Read Replies (1) of 1185
 
Mr. Forthright:

Nortran came to one of our investment conferences last year. I liked the company, met management, went at my own expense to visit the company, have spent countless hours researching it and writing about it, and said when the stock was at around $0.77 that it should be fairly valued at $2.16 (no one else was saying that in widespread print, to my knowledge). This steady upward trend, at least to the low two's was the stock catching up with the value. Last time I checked, this was an analytical tribute and not an offshoot of promotion.

But, without the brilliance of the people at NRT, my predictions, valuation, good words and critical words (of which I have supplied plenty), would have amounted to nothing.

I have merely benefitted from the diligence, guts and vigor demonstrated by everyone involved at NRT. Something that I recognized about the people immediately upon meeting them.

I am quite happy for people like Wisee, Paul S., SOROS, et al, who saw the same characteristics in the firm that I did. These people are much better off today than they were in January as a result. i hope you were as fortunate.

FJA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext